The overall goal of the U.S. National Drug Control Strategy, which is prepared by the White House Office of National Drug Control Policy (ONDCP), is to reduce illicit drug use in the United States. One of the strategy's priorities is to disrupt the illicit drug marketplace. To this end, since fiscal year 2000, the United States has provided about $397 million to support Mexican counternarcotics efforts. According to the Department of State (State), much of the illicit drugs consumed in the United States flows through or is produced in Mexico. GAO examined (1) developments in Mexican drug production and trafficking since calendar year 2000 and (2) U.S. counternarcotics support for Mexico since fiscal year 2000.
Recommendations for Executive Action
|Office of National Drug Control Policy||1. To help counter the increasing threat of illicit drugs reaching the United States from Mexico, the Director of ONDCP should, as the lead agency for U.S. drug policy, in conjunction with the cognizant departments and agencies in the U.S. counternarcotics interagency community, coordinate with the appropriate Mexican officials before completing the Southwest Border Counternarcotics Strategy's implementation plan to help ensure Mexico's cooperation with any efforts that require it and address the cooperation issues we identified. To help maximize ongoing U.S. assistance programs, such efforts should include, but not be limited to (1) promoting greater cooperation and coordination between Defense and the Mexican military services; (2) agreeing to a maritime cooperation agreement; (3) resolving the personnel status issue to allow aerial patrols along the U.S.-Mexico border to resume; and (4) reviewing Mexico's overall aviation requirements for interdiction purposes and determining how best the United States can assist.|